Study Title: Pemf Therapy for the Management of Diabetes in Obese Patients (PROMISE)

NCT Number: NCT04183543

Summary: The PROMISE pilot trial will investigate whether metabolic activation of muscle with a novel, non-invasive technology will further improve metabolic outcomes in overweight/obese patients with early T2DM who are currently given diet and/ or lifestyle interventions.
Dates: December 2019-October 2021
Principal Investigators: Alfredo Franco-Obregón, Asim Shabbir

Click here to read more